Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kenji Nakaya is active.

Publication


Featured researches published by Kenji Nakaya.


Bioorganic & Medicinal Chemistry | 1999

7-Chloro-5-hydroxy-1-[2-methyl-4-(2-methylbenzoyl-amino)benzoyl ]-2,3,4,5-tetrahydro-1H-1-benzazepine (OPC-41061): a potent, orally active nonpeptide arginine vasopressin V2 receptor antagonist.

Kazumi Kondo; Hidenori Ogawa; Hiroshi Yamashita; Hisashi Miyamoto; Michinori Tanaka; Kenji Nakaya; Kazuyoshi Kitano; Yoshitaka Yamamura; Shigeki Nakamura; Toshiyuki Onogawa; Toyoki Mori; Michiaki Tominaga

We previously reported a series of benzazepine derivatives as orally active nonpeptide arginine vasopressin (AVP) V2 receptor antagonists. After the lead structure OPC-31260 was structurally evaluated and optimized, the introduction of the 7-Cl moiety on the benzazepine and 2-CH3 on the aminobenzoyl moiety enhanced its oral activity. The new AVP-V2 selective antagonist OPC-41061 was determined to be a potent and orally active agent.


Journal of Medicinal Chemistry | 1996

Orally Active, Nonpeptide Vasopressin V2 Receptor Antagonists: A Novel Series of 1-[4-(Benzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepines and Related Compounds

Hidenori Ogawa; Hiroshi Yamashita; Kazumi Kondo; Yoshitaka Yamamura; Hisashi Miyamoto; Keizo Kan; Kazuyoshi Kitano; Michinori Tanaka; Kenji Nakaya; Shigeki Nakamura; Toyoki Mori; Michiaki Tominaga; Youichi Yabuuchi


Archive | 1992

Benzazepin derivatives as vasopressin antagonists

Hidenori Ogawa; Kazumi Kondo; Hiroshi Yamashita; Kenji Nakaya; Hajime Komatsu; Michinori Tanaka; Kazuyoshi Kitano; Michiaki Tominaga; Yoichi Yabuuchi


Journal of Medicinal Chemistry | 1993

Orally active, nonpeptide vasopressin V1 antagonists. A novel series of 1-(1-substituted 4-piperidyl)-3,4-dihdyro-2(1H)-quinolinone.

Hidenori Ogawa; Yoshitaka Yamamura; Hisashi Miyamoto; Kazumi Kondo; Hiroshi Yamashita; Kenji Nakaya; Tomihiko Chihara; Toyoki Mori; Michiaki Tominaga; Youichi Yabuuchi


Archive | 1993

Vasopressin antagonist and oxytocin antagonist

Hidenori Axa Nakase Nishinokoshi Ogawa; Kazumi Aza Inamoto Kondo; Hiroshi Yamashita; Kenji Nakaya; Hajime Komatsu; Michinori Tanaka; Kazuyoshi Nishiyamada Hinoki Kitano; Michiaki Tominaga; Yoichi Yabuuchi


Archive | 1991

Vasopressin antagonistic agent

Hajime Komatsu; Kazumi Kondo; Hisashi Miyamoto; Kenji Nakaya; Hidenori Ogawa; Shinya Takara; Michinori Tanaka; Michiaki Tominaga; Yoichi Yabuuchi; Hiroshi Yamashita


Archive | 1997

Thiazole derivative as protein kinase c inhibitors

Toyoki Mori; Michiaki Tominaga; Fujio Tabusa; Kazuyoshi Nagami; Kaoru Abe; Kenji Nakaya; Isao Takemura; Tomoichi Shinohara; Yoshihisa Tanada; Takahito Yamauchi


Archive | 1993

Benzoheterocyclic compounds and vasopressin antagonist and oxytocin antagonist compositions containing a benzoheterocyclic compound

Hidenori Ogawa; Kazumi Kondo; Hiroshi Yamashita; Kenji Nakaya; Hajime Komatsu; Michinori Tanaka; Kazuyoshi Kitano; Michiaki Tominaga; Yoichi Yabuuchi


Archive | 1991

Carbostyryl derivative and vasopressin antagonistic agent

Takafumi Fujioka; Kazuyoshi Kitano; Hajime Komatsu; Kazumi Kondo; Hisashi Miyamoto; Kenji Nakaya; Hidenori Ogawa; Michinori Tanaka; Shuji Teramoto; Michiaki Tominaga; Yoichi Yabuuchi; Hiroshi Yamashita; 賢治 中矢; 和良 北野; 寿 宮本; 道明 富永; 修二 寺本; 英則 小川; 一 小松; 博司 山下; 理紀 田中; 洋一 薮内; 孝文 藤岡; 一見 近藤


Archive | 1997

Thiazole derivate als protein kinase c inhibitoren Thiazoles derivatives as protein kinase inhibitors c

Toyoki Mori; Michiaki Tominaga; Fujio Tabusa; Kazuyoshi Nagami; Kaoru Abe; Kenji Nakaya; Isao Takemura; Tomoichi Shinohara; Yoshihisa Tanada; Takahito Yamauchi

Collaboration


Dive into the Kenji Nakaya's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge